Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03874234
Recruitment Status : Suspended (This study is on hold due to toxicity findings in a pre-clinical asset with the same mode of action as GSK'899. We are assessing the impact of these findings.)
First Posted : March 14, 2019
Last Update Posted : December 8, 2020
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : March 18, 2022
Estimated Study Completion Date : March 18, 2022